Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Diseases of the Thyroid

Free Subscription Articles published in J Nucl Med Retrieve available abstracts of 21 articles: HTML format Text format

Single Articles

May 2012
1. AVRAM AM
   Radioiodine Scintigraphy with SPECT/CT: An Important Diagnostic Tool for Thyroid Cancer Staging and Risk Stratification.
   J Nucl Med. 2012;53:754-64.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
2. 
   From the literature.
   J Nucl Med. 2012;53:22N-6.
   PubMed     Text format     Related articles   
   
   
   
   February 2012
3. DAM HQ , Manzone TA, Grady EC, Tulchinsky M, et al
   Utility of Diagnostic Whole-Body Iodine Scanning in High-Risk Differentiated Thyroid Carcinoma.
   J Nucl Med. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
4. VAN NOSTRAND D , Khorjekar GR, O'Neil J, Moreau S, et al
   Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in the Identification of Metastasis in Differentiated Thyroid Cancer with 131I Planar Whole-Body Imaging and 124I PET.
   J Nucl Med. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
5. KAUHANEN S , Schalin-Jantti C, Seppanen M, Kajander S, et al
   Complementary Roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in Medullary Thyroid Cancer.
   J Nucl Med. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. ZIESSMAN HA
   General nuclear medicine.
   J Nucl Med. 2011;52:20N-8N.
   PubMed     Text format     Related articles   
   
   
   
   October 2011
7. KIM JE , Ahn BC, Hwang MH, Jeon YH, et al
   Combined RNA Interference of Hexokinase II and 131I-Sodium Iodide Symporter Gene Therapy for Anaplastic Thyroid Carcinoma.
   J Nucl Med. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
8. WILD D , Fani M, Behe M, Brink I, et al
   First clinical evidence that imaging with somatostatin receptor antagonists is feasible.
   J Nucl Med. 2011;52:1412-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. DAUER LT , Zanzonico P, Tuttle RM, Quinn DM, et al
   The Japanese tsunami and resulting nuclear emergency at the Fukushima Daiichi power facility: technical, radiologic, and response perspectives.
   J Nucl Med. 2011;52:1423-32.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
10. ORA M , P M, Jain S, Barai S, et al
    The need for a low-expense universally acceptable rhTSH protocol.
    J Nucl Med. 2011;52:1166.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
11. GOLDSMITH SJ
    The real cost of theoretic risk avoidance: the need to challenge unsubstantiated concerns about (131)I therapy.
    J Nucl Med. 2011;52:681-2.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
12. HIGASHI T , Nishii R, Yamada S, Nakamoto Y, et al
    Delayed Initial Radioactive Iodine Therapy Resulted in Poor Survival in Patients with Metastatic Differentiated Thyroid Carcinoma: A Retrospective Statistical Analysis of 198 Cases.
    J Nucl Med. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
13. WALTER MA , Benz MR, Hildebrandt IJ, Laing RE, et al
    Metabolic imaging allows early prediction of response to vandetanib.
    J Nucl Med. 2011;52:231-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
14. DE MEER SG , Vriens MR, Zelissen PM, Borel Rinkes IH, et al
    The Role of Routine Diagnostic Radioiodine Whole-Body Scintigraphy in Patients with High-Risk Differentiated Thyroid Cancer.
    J Nucl Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. 
    Patient release issue reopened.
    J Nucl Med. 2010;51:13N.
    PubMed     Text format     Related articles   
    
    
    
    
16. 
    Professional groups respond.
    J Nucl Med. 2010;51:13N.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
17. HAUTZEL H , Pisar E, Yazdan-Doust N, Schott M, et al
    Qualitative and Quantitative Impact of Protective Glucocorticoid Therapy on the Effective 131I Half-Life in Radioiodine Therapy for Graves Disease.
    J Nucl Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
18. GREWAL RK , Tuttle RM, Fox J, Borkar S, et al
    The Effect of Posttherapy 131I SPECT/CT on Risk Classification and Management of Patients with Differentiated Thyroid Cancer.
    J Nucl Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
19. LASSMANN M , Hanscheid H, Gassen D, Biko J, et al
    In Vivo Formation of {gamma}-H2AX and 53BP1 DNA Repair Foci in Blood Cells After Radioiodine Therapy of Differentiated Thyroid Cancer.
    J Nucl Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
20. KRAEBER-BODERE F , Bodet-Milin C, Niaudet C, Sai-Maurel C, et al
    Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft.
    J Nucl Med. 2010;51:624-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
21. LIU B , Kuang A, Huang R, Zhao Z, et al
    Influence of Vitamin C on Salivary Absorbed Dose of 131I in Thyroid Cancer Patients: A Prospective, Randomized, Single-Blind, Controlled Trial.
    J Nucl Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: